The Company expects to submit the New Drug Application for Xulane Lo in the second half of 2025. A low dose combination hormonal patch was found to be effective for pregnancy prevention based on ...
PITTSBURGH, May 8, 2025 /PRNewswire/ -- Viatris Inc. (VTRS) (Nasdaq: VTRS), a global healthcare company, today announced positive results of its Phase 3 study (NCT05139121) evaluating the ...
Pearl Abyss responds to player demands with headgear visibility controls and massive storage upgrades. Camp expansions now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results